These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 120765)

  • 21. MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei.
    White KL; Snyder HL; Krzych U
    J Immunol; 1996 May; 156(9):3374-81. PubMed ID: 8617963
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complete protection against P. berghei malaria upon heterologous prime/boost immunization against circumsporozoite protein employing Salmonella type III secretion system and Bordetella adenylate cyclase toxoid.
    Tartz S; Rüssmann H; Kamanova J; Sebo P; Sturm A; Heussler V; Fleischer B; Jacobs T
    Vaccine; 2008 Nov; 26(47):5935-43. PubMed ID: 18804138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immune responses induced by intramuscular or gene gun injection of protective deoxyribonucleic acid vaccines that express the circumsporozoite protein from Plasmodium berghei malaria parasites.
    Leitner WW; Seguin MC; Ballou WR; Seitz JP; Schultz AM; Sheehy MJ; Lyon JA
    J Immunol; 1997 Dec; 159(12):6112-9. PubMed ID: 9550412
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization against rodent malaria with cryopreserved irradiated sporozoites of Plasmodium berghei.
    Orjih AU; Nussenzweig RS
    Am J Trop Med Hyg; 1980 May; 29(3):343-7. PubMed ID: 6992606
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of antimalaria immunity in mice lacking IFN-gamma receptor.
    Tsuji M; Miyahira Y; Nussenzweig RS; Aguet M; Reichel M; Zavala F
    J Immunol; 1995 May; 154(10):5338-44. PubMed ID: 7537305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
    Aly AS; Downie MJ; Mamoun CB; Kappe SH
    Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The protective antigen of malarial sporozoites (Plasmodium berghei) is a differentiation antigen.
    Aikawa M; Yoshida N; Nussenzweig RS; Nussenzweig V
    J Immunol; 1981 Jun; 126(6):2494-5. PubMed ID: 6785357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prospects for vaccination against malaria in man.
    Corradetti A
    Bull World Health Organ; 1974; 50(3-4):287-91. PubMed ID: 4216411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Macrophage cytotoxicity in lethal and non-lethal murine malaria and the effect of vaccination.
    Taverne J; Treagust JD; Playfair JH
    Clin Exp Immunol; 1986 Oct; 66(1):44-51. PubMed ID: 3542317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of immune complexes on immunity to Plasmodium berghei infection.
    Alder JD; Kreier JP
    Tropenmed Parasitol; 1984 Dec; 35(4):253-9. PubMed ID: 6395456
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of route of Mycobacterium bovis BCG administration on induction of suppression of sporozoite immunity in rodent malaria.
    Smrkovski LL
    Infect Immun; 1981 Jan; 31(1):408-12. PubMed ID: 7012001
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intramuscular immunization of mice with irradiated Plasmodium berghei sporozoites. Enhancement of protection with albumin.
    Kramer LD; Vanderberg JP
    Am J Trop Med Hyg; 1975 Nov; 24(6 Pt 1):913-6. PubMed ID: 1106231
    [No Abstract]   [Full Text] [Related]  

  • 33. Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.
    Nussenzweig RS; Vanderberg J; Most H; Orton C
    Nature; 1967 Oct; 216(5111):160-2. PubMed ID: 6057225
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasmodium berghei malaria: effect of acute phase serum on immunity generated in rats by infection and by vaccination.
    Alder JD; Brooks-Alder B; Kreier JP
    Parasitol Res; 1987; 74(2):116-22. PubMed ID: 3325980
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inflammation and resistance of mice against "Plasmodium berghei" (author's transl)].
    Michel JC; Hurtrel B; Lagrange PH
    Ann Immunol (Paris); 1982; 133C(1):97-101. PubMed ID: 7046621
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. IV. Dose response, specificity and humoral immunity.
    Nussenzweig R; Vanderberg J; Most H
    Mil Med; 1969 Sep; 134(10):1176-82. PubMed ID: 4987036
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites.
    Vanderberg J; Nussenzweig R; Most H
    Mil Med; 1969 Sep; 134(10):1183-90. PubMed ID: 4987037
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-temperature preservation of sporozoites of Plasmodium berghei.
    Leef JL; Strome CP; Beaudoin RL
    Bull World Health Organ; 1979; 57 Suppl 1(Suppl):87-91. PubMed ID: 120776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasmodium berghei: protection against sporozoites by normal mosquito tissue vaccination of mice.
    Alger NE; Harant J
    Exp Parasitol; 1976 Oct; 40(2):269-72. PubMed ID: 9307
    [No Abstract]   [Full Text] [Related]  

  • 40. Correlation between genetic regulation of antibody responsiveness and protective immunity induced by Plasmodium berghei vaccination.
    Heumann AM; Stiffel C; Monjour L; Bucci A; Biozzi G
    Infect Immun; 1979 Jun; 24(3):829-36. PubMed ID: 112057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.